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Knowledge and Perceptions of HPV Vaccine
Acceptance among African-American College
Women
Lauren R. Darensbourg, MPH, Ivette A. López, PhD,
Matthew T. Dutton, PhD, C. Perry Brown, DrPH
ABSTRACT
Human papillomavirus (HPV) is the most prevalent sexually transmitted disease in the United States. Prevalence rates
among sexually active young women are approximately 50%. An HPV vaccine has been created that has high efficacy
in preventing persistent HPV infection, cervical cancer precursor lesions, and genital warts caused by four HPV
subtypes. The purpose of this study was to assess African-American college women’s knowledge and perceptions of
HPV, and their association with the acceptance of HPV vaccination. Variable selection was guided by the Health
Belief Model and the Theory of Planned Behavior. Written surveys were administered to 122 African-American women
between the ages of 18 and 26 who were enrolled as undergraduates at Florida Agricultural and Mechanical
University (FAMU). Statistically significant associations were found between planning to get vaccinated against HPV
and several perception variables. Health education efforts aimed at African-American women in college should be
renewed, given the high percentage of misconceptions about HPV among members of the study population.
Interventions should appeal to social networks of the young women, as their opinions regarding the vaccine weighs in
their decision to plan to get vaccinated. This study underscores the need for continuous and consistent health education
interventions directed at African-American women of college age.
Florida Public Health Review, 2015; 12, 34-40.
BACKGROUND
Approximately 25 million women ages 14-59
carry the human papillomavirus (HPV). Prevalence
increases yearly among women starting at age 14 and
peaks at 45% among women 20 to 24 (Dunne, 2007;
Gonik, 2006; Slomovitz, Sun, Frumovitz, Soliman,
Schmeler, et al. 2006). HPV is often contracted by
adolescents and young adults shortly after the onset of
sexual activity (Hoover, 2000). Moreover, a Centers
for Disease Control and Prevention (CDC) study based
on an analysis of the 2003-2004 National Health and
Nutrition Examination Survey estimates that one in
four (26%) young women between the ages of 14 and
19 in the United States – or 3.2 million teenage girls –
are infected with at least one of the most common
sexually transmitted diseases: HPV, chlamydia, herpes
simplex virus, and trichomoniasis (CDC, 2008). Of
these, HPV is the most prevalent.
HPV infection has been established as the most
important causative factor of cervical cancer, as well as
penile and anal cancers (Muñoz et al, 2003; Muñoz et
al., 2000; Walboomers et al., 1999). HPV infection
also leads to clinically apparent genital warts in 10.5%
of all infections among women 25-34 years of age
Florida Public Health Review, 12, 34-40.

(Dempsey, Koutsky & Golden, 1997). Although this
number is relatively small, genital warts can cause
considerable morbidity and emotional stress for
patients, as well as increased risk for cervical cancer.
A prophylactic human papillomavirus (HPV)
vaccine has been developed called Gardasil®
(Markowitz et al., 2007). Clinical trials of the vaccine
indicate that it has high efficacy in preventing
persistent HPV infection, cervical cancer precursor
lesions, vaginal and vulvar cancer precursor lesions,
and genital warts caused by HPV types 6, 11, 16, or 18
among girls and women who have not previously been
infected with the respective HPV type (Markowitz et
al., 2007). Knowledge among the general population
remains sparse regarding both HPV and the HPV
vaccine to prevent infection and future development of
cervical cancer (Licht et al, 2010; Hopenhayn, 2007).
Also, because HPV is sexually transmitted, cervical
cancer also may be classified as a sexually transmitted
infection (STI), which raises concerns of a possible
stigma (Hopenhayn, 2007). However, one study found
that presenting a vaccine to prevent sexually related
problems did not seem to be a deterrent to its
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acceptance (Boehner, 2003). In fact, the same study
found that college students were willing to accept a
vaccine for an STI because there are so many
individuals that have perceived susceptibility to the
diseases (Boehner, 2003). Consistent with the previous
study’s findings, Hoover et al. (2000) found that girls
and young women actually preferred a vaccine that
targeted the STI rather than cervical cancer. Young
women’s acceptance of the vaccine also will be
affected by the roles of their peers, their healthcare
coverage or the cost-effectiveness of the vaccine, as
well as educational campaigns on HPV transmission
and the effects of HPV infection on cervical cancer
risk within their community (Zimet et al., 1997; Zimet
et al., 2000). Markowitz et al. (2013) showed that the
vaccine had reduced overall HPV prevalence among
females aged 14-19 but did not consider racial and
ethnic differences in vaccine acceptance.
Previous studies in the United States show that
knowledge of HPV is limited among adolescents,
university undergraduates, and even women with
abnormal Pap smears referred for further testing
(Rosenthal et al, 2011; Licht et al, 2010; Hoover,
2007). D’Urso, Thompson-Robinson and Chandler
(2007) found that lack of awareness knowledge of
HPV was high in a sample of black college students at
a historically black university. Yet, few studies to date
have evaluated perceptions of the HPV vaccine among
African-American women. The purpose of this study is
to assess the knowledge and perceptions of HPV and
acceptability of the HPV vaccine among AfricanAmerican college women enrolled at Florida A&M
University, a premier historically black college/
university (HBCU).
The theoretical framework that provides the
foundation for this study is the Theory of Planned
Behavior (TPB) (Ajzen, 1991). The TPB explores the
relationship between behavior, attitudes and behavioral
intentions. This theory was utilized to help determine if
there is an association between African-American
college women planning to get the HPV vaccine and
their own normative, behavioral, and control beliefs.
The knowledge variable was added to provide insight
into whether or not an association exists between the
modifying factors of HPV knowledge among AfricanAmerican college women and to determine if this
association would influence their perceived threat of
disease and intention to be vaccinated against HPV.
METHODS
We used a cross-sectional research design to
survey African-American college women’s knowledge
and perceptions of HPV and the HPV vaccine. The
study was reviewed and approved by the Institutional
Florida Public Health Review, 12, 34-40.

Review Board of Florida A&M University (FAMU
IRB), and a signed informed consent form was
obtained from each study participants.
We used a convenience sample; participants were
recruited from 5 different classes of the journalism and
psychology departments at FAMU. A total of 122
eligible students participated. The entire sample was
female, and 98% were African-American. Sample
participants ranged in age from 18 to 25, and were
mostly freshmen (30.3%) or seniors (34.4%) (Table 1).
Data were derived from self-reported confidential
surveys supplied by the 122 eligible participants. No
overlap occurred within the study samples.
Table 1. Demographic
Participants
Characteristic

Characteristics

Percentage

of

Study

Sample Size

Gender
Female

100.0

122

18 – 19
20 – 21
22 – 25

33.6
34.4
32.0

41
42
39

Age

Race
African American 97.5
Mixed Race
2.5
Classification
Freshman
Sophomore
Junior
Senior

30.3
15.6
19.7
34.4

119
3

37
19
24
42

Instruments
The survey instrument was a self-administered,
confidential questionnaire with three sections: (1) HPV
knowledge; (2) HPV vaccine perceptions; and (3)
demographics. The sample was recruited from selected
classes after permission was granted from the
respective professors. On an agreed upon day, the
researcher came at the beginning of class, described
the study, and asked for volunteer participants. Women
who volunteered to answer the self-administered
survey completed them in the classroom, after reading
and signing the informed consent form. The researcher
then collected the completed surveys.
HPV Knowledge Test
A 17-item knowledge test was administered to the
participants. This test was adapted using the Digene
HPV Test (Digene, 2007). A knowledge variable was
included in this study to account for any confounding
potential, as well as to assess its significance in
covariate and multivariate analyses. The inclusion of
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the knowledge test is not guided by the Theory of
Planned Behavior.
HPV Vaccine Perceptions Test
This 14-item selection of survey questions was
guided by the Theory of Planned Behavior, and
addresses the following theoretical constructs and
concepts: behavioral intention (dependent variable);
subjective norm, attitude toward behavior, normative
beliefs, and perceived behavioral control (independent
variables). Responses were measured using a 7-item
Likert scale with levels of agreement ranging from
‘Strongly Disagree’ to ‘Strongly Agree.’ Table 2
displays the theoretical constructs in relation to the
study variables that were established for this study.
Data Analysis
The responses to the HPV Knowledge test were
scored (number of correct responses/total number of
questions) for descriptive analysis to determine
knowledge levels among students as well as for use in
multivariate analysis. Bivariate analyses were utilized
to determine if correlations existed between the
dependent variable (planning to be vaccinated against
HPV) and the independent variables derived from the
Theory of Planned Behavior (HPV and HPV vaccine
knowledge and perceptions). For multivariate analyses,
responses to the HPV Perceptions Test were recoded
into binary variables (Agree, Disagree/No Opinion). A
multivariate logistic regression model was employed to
determine which independent variables (subjective
norm, normative beliefs, attitude toward the behavior,
and perceived behavioral control) were associated with
planning to be vaccinated against HPV (behavioral
intent). A stepwise elimination procedure was used
until all variables were statistically significant at α =
.05 in the final model. All analyses were conducted
using SPSS version 13.0 statistical software (SPSS
Inc., Chicago, Illinois).
RESULTS
The proportion of correct answers on the HPV
Knowledge Test ranged from 35% to 100%, with a
mean of 74%. Of the 122 participants, 53.3% (n = 65)
did not know that HPV was the most common STD in
the United States.; 53.3% (n = 65) thought HPV was
only transmitted through vaginal and anal sexual
intercourse; moreover, 52.5% (n = 64) thought HPV
did not affect both men and women. Bivariate and
multivariate analyses revealed no significant
correlations or associations between scores on the HPV

Florida Public Health Review, 12, 34-40.

Table 2. Theoretical Constructs and Selected Study
Variables for Theory of Planned Behavior (TPB)
Behavioral Intention
o I plan to get vaccinated against HPV.

Normative Beliefs
o My family thinks I should get vaccinated against HPV.
o My friends think I should not get vaccinated against HPV.
o When it comes to getting vaccinated, my family’s opinion is
important.
o When it comes to getting vaccinated, my friends’ opinions are
important.

Subjective Norm
o Many people like me are vaccinated against HPV.
o If a celebrity whose opinions I value would approve of the HPV
vaccine, I would be more likely to get vaccinated.
o I would be more likely to be vaccinated if influential women
whose opinions I value would approve of my vaccination.

Attitude toward the Behavior
o Vaccination is bad.
o Vaccination is valuable.

Perceived Behavioral Control
o If I wanted to, I could get vaccinated against HPV.
o It is mostly up to me whether or not I get vaccinated against HPV.

Modifying Factor (cognitive measure external to TPB)
o HPV Knowledge Test.

knowledge test and planning to be vaccinated against
HPV in this population.
Statistically significant correlations were found at
α = .05 level between planning to be vaccinated against
HPV and: agreeing that ‘Vaccination is valuable,’
agreeing that ‘I could get vaccinated if I wanted to,’
disagreeing that ‘My family thinks I should get
vaccinated against HPV,’ disagreeing that ‘Most
people important to me think I should not be
vaccinated against HPV,’ and disagreeing that ‘I would
be more likely to get vaccinated if influential women
whose opinions I value would approve of my
vaccination.’ Table 3 presents the bivariate results.
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Table 3. Bivariate Results: HPV Perceptions Associated
with Vaccination Intent
Statement

Spearman
correlation

p value

o Vaccination is bad.

.083

.365

o Vaccination is valuable.

.539*

<.001

o I could get vaccinated if
I wanted to.

.287*

.001

o My family thinks I should
be vaccinated.

.252*

.005

o Important people think I
should not get vaccinated.

.269*

.003

o More likely to get
vaccinated
if
valued
influential women would
approve of vaccination.

.528*

<.001

*Indicates the correlation is significant at the .05 level (2-tailed).

Table 4. Multivariate Results of HPV Perceptions Test:
Logistic Regression
Characteristic

Classification
Freshman (Reference group)
Sophomore
Junior
Senior

Odds
Ratio

p value

.491
.108
1.118

.422
.009*
.880

Vaccination is valuable.
No Opinion or Disagree (Reference
group)
Agree
5.805
.015*
My family thinks I should get
vaccinated.
No Opinion or Disagree (Reference
group)
Agree
10.877
.008*
If influential women whose opinions
I valued approved of my vaccination,
I would be more likely to get
vaccinated.
No Opinion or Disagree (Reference
group)
Agree
6.496
.003*
*Indicates the association is significant at the 0.05 level (2-tailed).

In the multivariate model for HPV perceptions
(i.e., intent to be vaccinated against HPV), there were
no significant associations between HPV knowledge
and planning to be vaccinated in this population.
However, after stepwise elimination, variables
measuring attitude toward planning to get vaccinated
for HPV, normative beliefs, and social norms related to
Florida Public Health Review, 12, 34-40.

the HPV vaccine were found to be significantly
associated with planning to get vaccinated against
HPV in this population. Table 4 displays the odds
ratios (OR) and p-values of the significant predictors.
The following factors were found to be significantly
associated: being a college Junior increased the
likelihood of vaccination relative to being a Freshman;
those who agreed ‘Vaccination is valuable’ were over
5 times more likely to plan to be vaccinated than those
who disagreed/had no opinion; those who agreed ‘My
family thinks I should get vaccinated against HPV’
were almost 11 times more likely to plan to be
vaccinated than those who disagree/had no opinion;
those who agreed ‘I would be more likely to get
vaccinated against HPV if influential women whose
opinions I valued approved of my vaccination’ were
6.5 times more likely to plan to be vaccinated than
those who did not agree; all other variables were not
significant at the α = .05 level.
DISCUSSION
In this study, we examined African American
college women’s level of HPV knowledge and
perceptions of HPV and the HPV vaccine in
association to planning to be vaccinated against HPV.
Although HPV knowledge was not found to be
significantly correlated or associated with planning to
be vaccinated against HPV in this population,
constructs of the Theory of Planned Behavior such as,
attitude toward the behavior, subjective norms, and
normative beliefs were found to influence planning to
be vaccinated against HPV. Further, there was an
overall high intent to be vaccinated against HPV in this
population (68%). This study has the potential to
become important to the development and
implementation of public health strategies and
interventions to increase awareness and education of
HPV and the HPV vaccine among African American
young women on college campuses across the nation.
The finding of low knowledge levels among
participating women is not dissimilar from other study
results. D’Urso and colleagues (2007) found that black
students at one HBCU were as misinformed about
HPV as their white counterparts.
The study
participants reported alarming misconceptions,
although different knowledge tests were utilized
(D’Urso et al, 2007). Clearly, there is an urgent need
to address the lack of accurate HPV information
created for this population segment.
Despite the level of misinformation, most of the
participants had a positive outlook regarding the HPV
vaccine. Whereas this is a mostly constructive finding,
the HPV vaccination decision should optimally be
taking place at an earlier age (ideally 9-13 years of age,
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but any time after that until the age of 26), in order to
benefit fully from the vaccines protection. Therefore,
the benefit of the vaccine is limited due to risky sexual
activity that a young woman may have participated in
by the time she attends college. Some of the negative
associations between being a junior college student
(presumably older) and the behavioral intent of getting
the HPV vaccine may be related to the women’s
perception that it may be too late for them.
Regarding the multivariate model for HPV
perceptions (i.e. intent to be vaccinated against HPV),
the following factors were found to be significantly
associated: being a college Junior, agreeing
‘Vaccination is valuable,’ agreeing ‘My family thinks I
should get vaccinated against HPV,’ and agreeing ‘I
would be more likely to get vaccinated against HPV if
influential women whose opinions I valued approved
of my vaccination.’ Regarding the association of
intent to vaccinate and agreeing the “vaccination is
valuable” and “my family thinks I should get
vaccinated against HPV,” these are areas where health
education interventions tailored for African American
young women should center. The importance of
familial support for vaccination is supported by much
of the literature despite barriers to vaccine acceptance
among many parents (Keane et al, 2005; Taylor et al,
2002; Diekema, 2005, Davis et al, 2004).
Furthermore, positive perceptions of the vaccine
(‘vaccination is valuable’) were expressed by a
majority of the study participants. Yet since these
perceptions showed a significant association with
vaccination intent, they should be an area of focus for
health education interventions.
Finally, the last
significant associations were found between intent to
vaccinate and agreement with ‘I would be more likely
to get vaccinated against HPV if influential women
whose opinions I valued approved of my vaccination.’
The study participants express openness toward a
female role model regarding the vaccination. The
opinions of influential others are clearly associated
with the intention of becoming vaccinated against
HPV. A physician’s recommendation may have also
swayed some women, as stated by Rosenthal et al
(2011), but this was not measured in the present study.
Health educators and service providers should
incorporate the social influence of family members,
friends, peers and role models.
Conclusion
In conclusion, HPV interventions should be
developed taking into consideration the opinions of the
social networks in the lives of African American
college women. Emphasis should be placed on
comprehensive sexual education given the high
Florida Public Health Review, 12, 34-40.

misconceptions about HPV within this population, and
should focus on education, awareness and prevention
of HPV, cervical cancer, and genital warts.
Furthermore, public health initiatives should be
tailored to account for the differences in perceptions
between different college classifications.
Limitations for this study may have included
instrument bias, as reliability of the tests were not
obtained. The small sample size may have impeded
the detection of existing correlations. Future studies
on HPV should explore the knowledge and perceptions
of males because knowing which factors influence
their intention to be vaccinated against HPV will be
important in the effective development of audience
appropriate HPV awareness and prevention
interventions. A larger study sample should be
recruited to make the data set more generalizable to the
national population and to support the data analyses to
be run. Moreover, future studies should explore the
possibility of an association between intent to get
vaccinated against HPV and perceived threat and
severity of HPV (Health Belief Model), as well as
control and behavioral beliefs related to intent to be
vaccinated against HPV (Theory of Planned Behavior).
Additionally, a factor analysis should be performed on
the HPV knowledge test to develop a knowledge scale
to further explore if an association exists between HPV
knowledge and intent to be vaccinated against HPV.
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